Your shopping cart is currently empty

RRD-251 is a specific small-molecule disruptor of the Rb-Raf-1 interaction. By blocking the physical binding between the Rb protein and Raf-1 kinase, it inhibits downstream cell cycle progression and survival signaling without affecting Rb-E2F1 binding. Research indicates that RRD-251 effectively induces apoptosis in various tumor cells, particularly metastatic melanoma, and demonstrates significant synergistic enhancement in combination chemotherapy studies.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $40 | - | In Stock | |
| 10 mg | $60 | - | In Stock | |
| 25 mg | $113 | - | In Stock | |
| 50 mg | $163 | - | In Stock | |
| 100 mg | $228 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $44 | - | In Stock |
| Description | RRD-251 is a specific small-molecule disruptor of the Rb-Raf-1 interaction. By blocking the physical binding between the Rb protein and Raf-1 kinase, it inhibits downstream cell cycle progression and survival signaling without affecting Rb-E2F1 binding. Research indicates that RRD-251 effectively induces apoptosis in various tumor cells, particularly metastatic melanoma, and demonstrates significant synergistic enhancement in combination chemotherapy studies. |
| In vitro | RRD-251 specifically disrupts the Rb-Raf-1 complex and induces apoptosis in metastatic melanoma cells by activating caspase-3 and inducing G1-phase arrest [1]. |
| In vivo | n melanoma xenograft models, systemic administration of RRD-251 significantly inhibits tumor growth and shows marked synergy when combined with the chemotherapeutic agent dacarbazine [1]. |
| Molecular Weight | 271.59 |
| Formula | C8H9Cl3N2S |
| Cas No. | 72214-67-6 |
| Smiles | Cl.ClC1=CC=C(C(Cl)=C1)CSC(=N)N |
| Storage | keep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (368.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.